Chemotherapeutic Peritoneal Perfusion

There is no standard treatment for peritoneal dissemination from gastric cancer. A novel treatment consisting of peritonectomy… Expand

BACKGROUND/AIMS Although the most frequent cause of death after curative resection of advanced gastric cancer is peritoneal… Expand

AbstractBackground: Primary peritoneal mesothelioma is a locally aggressive disease that is difficult to treat or even palliate… Expand

Thirty-two patients with advanced gastric cancer underwent continuous hyperthermic peritoneal perfusion (CHPP) combined with… Expand

PURPOSE Peritoneal mesothelioma remains a difficult therapeutic challenge. Aggressive debulking combined with continuous… Expand

BACKGROUND The most common cause of noncurative resection and recurrence is gastric cancer is peritoneal seeding. However, the… Expand

Background. Continuous hyperthermic peritoneal perfusion (CHPP) with a solution that contained 10 μg/ml mitomycin C was devised… Expand

A total of 31 patients with gastric cancer showing peritoneal dissemination received continuous hyperthermic peritoneal perfusion… Expand

Continuous hyperthermic peritoneal perfusion (CHPP) with a solution that contains mitomycin C (CHPP‐M) has been clinically… Expand

To study the feasibility of combined hyperthermic and anticancer drug treatment for peritoneal cancer, we devised a continuous… Expand